DFMO

March 31st, 2017   |   by: Antonia Palmer

DFMO is an interesting drug, and one that is currently being considered for a future clinical trial in Canada for children with neuroblastoma. There is a great deal to understand about this drug – both in how it works and the process for opening up a clinical trial in Canada.

» CONTINUE READING

Subscribe to Neuroblastoma Canada
  • Twitter
  • Facebook
  • Digg
  • Stumble Upon
  • RSS
  • Sign up for our mailing list - Neuroblastoma Canada ListServ
  • Most Popular
  • Recent Articles

Events

  • Neuroblastoma Family Information Day

    Jan 20, 2018

    Please join The James Fund and the Hospital for Sick Children for the 2018 Neuroblastoma Family Information Day on January 20th at the SickKids Peter Gilgan Centre for Research and Learning.

    » CONTINUE READING

  • Advances in Neuroblastoma Research (ANR) 2018

    May 9, 2018 - May 12, 2018

    “This meeting will provide a key opportunity for research scientists, clinicians, early career fellows, nurses and other allied health care workers to be updated on the latest basic, translational and clinical research developments in the field of childhood neuroblastoma.” The theme of the event is “Building Bridges for Neuroblastoma Research”. For more information, please see http://anr2018.org/.

    » CONTINUE READING

  • » VIEW ALL EVENTS